329 research outputs found
Bacteria and the evolution of honest signals. The case of ornamental throat feathers in spotless starlings
1. Mechanisms guaranteeing reliability of messages are essential in understanding the underlying
information and evolution of signals. Micro-organisms may degrade signalling traits and
therefore influence the transmitted information and evolution of these characters. The role of
micro-organisms in animal signalling has, however, rarely been investigated.
2. Here, we explore a possible role for feather-degrading bacteria driving the design of ornamental
throat feathers in male spotless starlings (Sturnus unicolor). We estimated length, bacterial
load, degradation status and susceptibility to degradation by keratinolytic bacteria in
those feathers, compared with non-ornamental adjacent feathers in males, as well as to throat
feathers in females. In addition, the volume of the uropygial gland and its secretion was measured
and the secretion extracted. We also experimentally evaluated the capacity of each secretion
to inhibit growth of a keratinolytic bacterium.
3. The apical part of male ornamental throat feathers harboured more bacteria and degraded
more quickly than the basal part; these patterns were not detected in female throat feathers or
in non-ornamental male feathers. Moreover, degradation status of male and female throat
feathers did not differ, but was positively associated with feather bacterial density. Finally, the
size of the uropygial gland in both males and females predicted volume and the inhibitory
capacity of secretion against feather-degrading bacteria. Only in males was uropygial gland
size negatively associated with the level of feather degradation.
4. All results indicate differential susceptibility of different parts of throat feathers to keratinolytic
bacterial attack, which supports the possibility that throat feathers in starlings reflect individual
ability to combat feather-degrading bacteria honestly. This is further supported by the
relationship detected between antimicrobial properties of uropygial secretion and the level of
feather degradation.
5. Our results suggest that selection pressures exerted by feather-degrading bacteria on hosts
may promote evolution of particular morphologies of secondary sexual traits with different
susceptibility to bacterial degradation that reliably inform of their bacterial load. Those results
will help to understand the evolution of ornamental signals.This work was financed by Spanish Ministerio de Ciencia e Innovaci on, European
funds (FEDER) (CGL2010-19233-C03-01, CGL2013-48193-C3-1-P). MRR and DMG received a postdoc from the program “JAE-Doc”, GT from the “Juan de la Cierva”, and CRC had a predoctoral fellowship, all from the Spanish Government.Peer reviewe
Cost-Efficacy of Surgically Induced Weight Loss for the Management of Type 2 Diabetes: A randomized controlled trial
OBJECTIVE -- To determine the within-trial cost-efficacy of surgical therapy relative to conventional therapy for achieving remission of recently diagnosed type 2 diabetes in class I and II obese patients. RESEARCH DESIGN AND METHODS -- Efficacy results were derived from a 2-year randomized controlled trial. A health sector perspective was adopted, and within-trial intervention costs included gastric banding surgery, mitigation of complications, outpatient medical consultations, medical investigations, pathology, weight loss therapies, and medication. Resource use was measured based on data drawn from a trial database and patient medical records and valued based on private hospital costs and government schedules in 2006 Australian dollars (AUD). An incremental cost-effectiveness analysis was undertaken. RESULTS -- Mean 2-year intervention costs per patient were 13,400 AUD for surgical therapy and 3,400 AUD for conventional therapy, with laparoscopic adjustable gastric band (LAGB) surgery accounting for 85% of the difference. Outpatient medical consultation costs were three times higher for surgical patients, whereas medication costs were 1.5 times higher for conventional patients. The cost differences were primarily in the first 6 months of the trial. Relative to conventional therapy, the incremental cost-effectiveness ratio for surgical therapy was 16,600 AUD per case of diabetes remitted (currency exchange: 1 AUD = 0.74 USD). CONCLUSIONS -- Surgical therapy appears to be a cost-effective option for managing type 2 diabetes in class I and II obese patients.<br /
The epidemiology of malaria in adults in a rural area of southern Mozambique
BACKGROUND: Epidemiological studies of malaria in adults who live in malaria endemic areas are scarce. More attention to the natural history of malaria affecting adults is needed to understand the dynamics of malaria infection and its interaction with the immune system. The present study was undertaken to investigate the clinical, parasitological and haematological status of adults exposed to malaria, and to characterize parasites in these individuals who progressively acquire protective immunity. METHODS: A cross-sectional survey of 249 adults was conducted in a malaria endemic area of Mozambique. Clinical, parasitological and haematological status of the study population was recorded. Sub-microscopic infections and multiplicity of infections were investigated using polymerase chain reaction (PCR) and restriction fragment length polymorphism of Plasmodium falciparum merozoite surface protein 2 (msp2). RESULTS: Prevalence of P. falciparum infection by microscopy (14%) and PCR (42%) decreased progressively during adulthood, in parallel with an increase in the prevalence of sub-microscopic infections. Anaemia was only related to parasitaemia as detected by PCR. Multiplicity of infection decreased with age and was higher in subjects with high P. falciparum densities, highlighting density-dependent constraints upon the PCR technique. CONCLUSION: Adults of Manhiça progressively develop non-sterile, protective immunity against P. falciparum malaria. The method of parasite detection has a significant effect on the observed natural history of malaria infections. A more sensitive definition of malaria in adults should be formulated, considering symptoms such as diarrhoea, shivering and headache, combined with the presence of parasitaemia
Changes in the total leukocyte and platelet counts in Papuan and non Papuan adults from northeast Papua infected with acute Plasmodium vivax or uncomplicated Plasmodium falciparum malaria
<p>Abstract</p> <p>Background</p> <p>There are limited data on the evolution of the leukocyte and platelet counts in malaria patients.</p> <p>Methods</p> <p>In a clinical trial of chloroquine vs. chloroquine plus doxycycline vs. doxycycline alone against <it>Plasmodium vivax </it>(n = 64) or <it>Plasmodium falciparum </it>(n = 98) malaria, the total white cell (WCC) and platelet (PLT) counts were measured on Days 0, 3, 7 and 28 in 57 indigenous Papuans with life long malaria exposure and 105 non Papuan immigrants from other parts of Indonesia with limited malaria exposure.</p> <p>Results</p> <p>The mean Day 0 WCC (n = 152) was 6.492 (range 2.1–13.4) × 10<sup>9</sup>/L and was significantly lower in the Papuans compared to the non Papuans: 5.77 × 10<sup>9</sup>/L vs. 6.86 × 10<sup>9</sup>/L, difference = -1.09 [(95% CI -0.42 to -1.79 × 10<sup>9</sup>/L), P = 0.0018]. 14 (9.2%) and 9 (5.9%) patients had leukopaenia (<4.0 × 10<sup>9</sup>/L) and leukocytosis (>10.0 × 10<sup>9</sup>/L), respectively. By Day 28, the mean WCC increased significantly (P = 0.0003) from 6.37 to 7.47 × 10<sup>9</sup>/L (73 paired values) and was similar between the two groups. Ethnicity was the only WCC explanatory factor and only on Day 0.</p> <p>The mean Day 0 platelet count (n = 151) was 113.0 (range 8.0–313.0) × 10<sup>9</sup>/L and rose significantly to 186.308 × 10<sup>9</sup>/L by Day 28 (P < 0.0001). There was a corresponding fall in patient proportions with thrombocytopaenia (<150 × 10<sup>9</sup>/L): 119/151 (78.81%) vs. 16/73 (21.92%, P < 0.00001). Papuan and non Papuan mean platelet counts were similar at all time points. Only malaria species on Day 0 was a significant platelet count explanatory factor. The mean D0 platelet counts were significantly lower (P = 0.025) in vivax (102.022 × 10<sup>9</sup>/L) vs. falciparum (122.125 × 10<sup>9</sup>/L) patients.</p> <p>Conclusion</p> <p>Changes in leukocytes and platelets were consistent with other malaria studies. The Papuan non Papuan difference in the mean Day 0 WCC was small but might be related to the difference in malaria exposure.</p
Why Functional Pre-Erythrocytic and Bloodstage Malaria Vaccines Fail: A Meta-Analysis of Fully Protective Immunizations and Novel Immunological Model
Background: Clinically protective malaria vaccines consistently fail to protect adults and children in endemic settings, and at best only partially protect infants. Methodology/Principal Findings: We identify and evaluate 1916 immunization studies between 1965-February 2010, and exclude partially or nonprotective results to find 177 completely protective immunization experiments. Detailed reexamination reveals an unexpectedly mundane basis for selective vaccine failure: live malaria parasites in the skin inhibit vaccine function. We next show published molecular and cellular data support a testable, novel model where parasite-host interactions in the skin induce malaria-specific regulatory T cells, and subvert early antigen-specific immunity to parasite-specific immunotolerance. This ensures infection and tolerance to reinfection. Exposure to Plasmodium-infected mosquito bites therefore systematically triggers immunosuppression of endemic vaccine-elicited responses. The extensive vaccine trial data solidly substantiate this model experimentally. Conclusions/Significance: We conclude skinstage-initiated immunosuppression, unassociated with bloodstage parasites, systematically blocks vaccine function in the field. Our model exposes novel molecular and procedural strategies to significantly and quickly increase protective efficacy in both pipeline and currently ineffective malaria vaccines, and forces fundamental reassessment of central precepts determining vaccine development. This has major implications fo
- …